Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure-Reference-Cited by-同舟云学术

Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure

Published:2024-09-10 Issue: Volume: Page:
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Secco Silvia^ORCID,Olivero Alberto,Longoni Mattia^ORCID,Dell’Oglio Paolo^ORCID,Tappero Stefano^ORCID,Dibilio Edoardo,Saccucci Tommaso,Siena Giampaolo^ORCID,Bocciardi Aldo Massimo,Galfano Antonio^ORCID,Cindolo Luca^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41391-024-00892-2.pdf

Reference11 articles.

1. Nguyen DD, Li T, Ferreira R, Baker Berjaoui M, Nguyen ALV, Chughtai B, et al. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation. Prostate Cancer Prostatic Dis. 2023;27:22–8.

2. Manfredi C, Arcaniolo D, Spatafora P, Crocerossa F, Fusco F, Verze P, et al. Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications. Minerva Urol Nephrol. 2022;74:389–99.

3. Amparore D, Fiori C, Valerio M, Schulman C, Giannakis I, De Cillis S, et al. 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2020;24:349–57.

4. Amparore D, De Cillis S, Schulman C, Kadner G, Fiori C, Porpiglia F. Temporary implantable nitinol device for benign prostatic hyperplasia-related lower urinary tract symptoms: over 48-month results. Minerva Urol Nephrol. 2023;75:743–51.

5. Sibona M, Destefanis P, Vercelli E, Secco S, Gontero P, Cindolo L. Ejaculation physiology and dysfunction after BPH surgery: the role of the new MISTs. Prostate Cancer Prostatic Dis. 2023;26:475–82.